Gilead's shares rise on report of experimental drug's promise in COVID-19
April 17, 2020 at 09:57 AM EDT
Shares of Gilead Sciences Inc rose 10% in early trading on Friday after a report that patients with COVID-19 treated with the company's experimental drug, remdesivir, in a clinical trial showed rapid recovery in fever and respiratory symptoms.